Major reason for mortality among systemic lupus erythematosus patients is renal failure due to the deposition of immune complexes in the glomeruli. Being a chronic disease with multiple relapses and remissions across the lifespan, it’s important to know the degree of nephritis for diagnosis as well as the long-term clinical management of the patients. Currently, renal biopsy is being used as the gold standard to diagnose and define the stages of the disease. However, renal biopsy being invasive only provides a localized picture of nephritis, and has the risk of bleeding. Additionally, it is also cost-intensive. Hence, a reliable, non-invasive biomarker is required for lupus nephritis. This study has evaluated extracellular mitochondrial components, including cell-free mitochondria, and cell-free mitochondrial DNA as probable biomarkers of the degree of nephritis. Both showed a significant correlation with proteinuria and protein-creatinine ratio. Our study substantiates their usage as clinical biomarkers of nephritis upon their validation in a larger cohort of lupus nephritis patients and other forms of nephritis. Although the current data suggest using cell-free mitochondria as a biomarker of lupus nephritis is better than the cell-free mitochondrial DNA.
DemaBCharlesN. Advances in mechanisms of systemic lupus erythematosus. Discov Med2014; 17(95): 247–255.
2.
Flores-MendozaGSansónSPRodríguez-CastroS, et al.Mechanisms of tissue injury in lupus nephritis. Trends Mol Med2018; 24(4): 364–378.
3.
HanlyJGO’KeeffeAGSuL, et al.The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology2016; 55(2): 252–262.
4.
CerveraRKhamashtaMAFontJ, et al.Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine2003; 82(5): 299–308.
5.
HoffmanIELauwerysBRDe KeyserF, et al.Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis2009; 68(3): 412–415.
6.
MoroniGVercelloniPGQuagliniS, et al.Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis2018; 77(9): 1318–1325.
7.
WardMM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982–1995. Arch Intern Med2000; 160(20): 3136–3140.
8.
CrocaSCRodriguesTIsenbergDA. Assessment of a lupus nephritis cohort over a 30-year period. Rheumatology2011; 50(8): 1424–1430.
9.
LerangKGilboeIMSteinar ThelleD, et al.Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study. Lupus2014; 23(14): 1546–1552.
10.
AringerMCostenbaderKDaikhD, et al.2019 European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol2019;71(9):1400–1412.
11.
BajemaIMWilhelmusSAlpersCE, et al.Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int2018; 93(4): 789–796.
12.
ChenTKEstrellaMMFineDM. Predictors of kidney biopsy complication among patients with systemic lupus erythematosus. Lupus2012; 21(8): 848–854.
13.
ThompsonJCMahajanAScottDA, et al.The economic burden of lupus nephritis: a systematic literature review. Rheumatology and therapy2021; 3: 1–23.
14.
RekvigOP. Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks. Clin Exp Immunol2015; 179(1): 5–10.
15.
BarreraMJAguileraSCastroI, et al.Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: potential role in Sjögren’s syndrome. Autoimmun Rev2021; 20(8): 102867.
16.
BoudreauLHDuchezACCloutierN, et al.Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood, The Journal of the American Society of Hematology2014; 124(14): 2173–2183.
17.
ZhangBAsadiSWengZ, et al.Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One2012; 7(12): e49767.
18.
TruszewskaAWirkowskaAGalaK, et al.Cell-free DNA profiling in patients with lupus nephritis. Lupus2020; 29(13): 1759–1772.
19.
OuZLiKYangT, et al.Detection of bladder cancer using urinary cell-free DNA and cellular DNA. Clin Transl Med2020; 9(1): 1–2.
20.
HuQRenJRenH, et al.Urinary mitochondrial DNA identifies renal dysfunction and mitochondrial damage in sepsis-induced acute kidney injury. Oxid Med Cell Longev2018; 2018: 8074936.
21.
FlachaireEDamourOBienvenuJ, et al.Assessment of the benzethonium chloride method for routine determination of protein in cerebrospinal fluid and urine. Clin Chem1983; 29(2): 343–345.
22.
JaffeM. About the precipitate that picric acid produces in normal ears and about a new reaction of creatinine. Z Physiol Chem1886; 10: 391–400.
23.
VidaTAEmrSD. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol1995; 128(5): 779–792.
NelissenKSmeetsKMulderM, et al.Selection of reference genes for gene expression studies in rat oligodendrocytes using quantitative real time PCR. J Neurosci Methods2010; 187(1): 78–83.
26.
BodaEPiniAHoxhaE, et al.Selection of reference genes for quantitative real-time RT-PCR studies in mouse brain. J Mol Neurosci2009; 37(3): 238–253.
27.
KimKMoonHLeeYH, et al.Clinical relevance of cell-free mitochondrial DNA during the early postoperative period in kidney transplant recipients. Sci Rep2019; 9(1): 1–9.
28.
CreweCFunckeJBLiS, et al.Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metabol2021; 33(9): 1853–1868.
29.
GargMJohriSChakrabortyK. Immunomodulatory role of mitochondrial DAMPs: a missing link in pathology?FEBS J2022; 290: 4395–4418.
30.
CrouserEDShaoGJulianMW, et al.Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med2009; 37(6): 2000.
31.
MaoYMZhaoCNLiuLN, et al.Increased circulating interleukin-8 levels in systemic lupus erythematosus patients: a meta-analysis. Biomarkers Med2018; 12(11): 1291–1302.
32.
RovinBHLuLZhangX. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int2002; 62(1): 261–265.
33.
KimJGuptaRBlancoLP, et al.VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science2019; 366(6472): 1531–1536.
34.
FernandezDRPabonMAOlferievM, et al.II-19 Elevated plasma cell-free mitochondrial DNA defines a subgroup of lupus patients with membranous lupus nephritis.
